HYDROCORTISONE ACETATE / IODOQUINOL TOPICAL CREAM [SKYNPLEX]

Side Effects & Adverse Event Reports


View Chart Data

28.5K

Adverse Events

458.7K

Side Effects

2012

Data Starting In

SymPedia Mobile App

Get our Mobile App for easy access to the latest reports on HYDROCORTISONE ACETATE / IODOQUINOL TOPICAL CREAM [SKYNPLEX].

Understanding the potential Side Effects and Adverse Events of HYDROCORTISONE ACETATE / IODOQUINOL TOPICAL CREAM [SKYNPLEX] is essential for making informed health decisions. Our application provides in-depth reports based on real-world data, helping you explore how HYDROCORTISONE ACETATE / IODOQUINOL TOPICAL CREAM [SKYNPLEX] may affect your health.

View reports containing much more information including:

  • Age group - See how different age ranges experience side effects and adverse reactions.
  • Year - Track trends over time to understand changes in reported issues.
  • Biological sex - Compare how reports vary between men and women.
  • Weight - Examine the impact of body weight on side effects and adverse events.
Download Now

Frequently Asked Questions

Some questions about HYDROCORTISONE ACETATE / IODOQUINOL TOPICAL CREAM [SKYNPLEX] are asked frequently. We've answered the most frequent of those questions below

  • How many adverse events have been reported for HYDROCORTISONE ACETATE / IODOQUINOL TOPICAL CREAM [SKYNPLEX]?

    SymPedia shows HYDROCORTISONE ACETATE / IODOQUINOL TOPICAL CREAM [SKYNPLEX] adverse event reports for 28,485.

  • How many side effects have been reported for HYDROCORTISONE ACETATE / IODOQUINOL TOPICAL CREAM [SKYNPLEX]?

    SymPedia shows HYDROCORTISONE ACETATE / IODOQUINOL TOPICAL CREAM [SKYNPLEX] side effect reports for 458,668.

  • What year does the HYDROCORTISONE ACETATE / IODOQUINOL TOPICAL CREAM [SKYNPLEX] reporting data start?

    SymPedia reporting data on this page starts in 2012.

  • What years are included in the yearly chart for HYDROCORTISONE ACETATE / IODOQUINOL TOPICAL CREAM [SKYNPLEX]?

    SymPedia yearly chart data on this page covers 2012 to 2025.